EverQuote, Inc.

EVER

CIK 0001640428 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$195M
↑+32.5% +$48Mvs FY2024 (Q4)
Operating Income
$19M
↑+54.9% +$7Mvs FY2024 (Q4)
Net Income
$19M
↑+60.6% +$7Mvs FY2024 (Q4)
Gross Profit
$191M
↑+34.4% +$49Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Excellent
99/100
  • Profitability
    100ROIC 31.2% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 2.94 (above 1.5 = solid)
  • Leverage
    100D/E -0.08 (under 0.5 = conservative)
  • Efficiency
    100Asset Turnover 2.58x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +32.5% (10% = solid, 25%+ = elite)
  • Margin Trend
    91Op Margin 9.5% · trend +2.5pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project EVER's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$41.16
Total enterprise IV
$1.55B
Diluted shares
0.04B
Terminal PV
$1.13B (72% of total)
Year-5 FCF
$133M
YearProjected FCFDiscounted PV
+1$98M$89M
+2$105M$87M
+3$114M$85M
+4$123M$84M
+5$133M$82M
Terminal$1.81B$1.13B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$5M
investment in PP&E
Stock buybacks (TTM)
$12M
share count reduction
Stock-based comp (TTM)
$24M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$327M
everything owned
Total liabilities
$89M
everything owed
Stockholders' equity
$238M
shareholder claim
Net debt
$-164M
Net cash position ($164M)

Recent performance · 36 quarters

Revenue↑+32.5% +$48M
$195M
Net Income↑+369.3% +$45M
$58M
Free Cash Flow↑+35.1% +$7M
$26M
Operating Margin↑+1.4pts
9.5%

Drill down